The Brazilian Health Regulatory Agency (ANVISA) granted approval for the FlareHawk7 and FlareHawk9 spine implant devices.
State of Alaska Department of Revenue reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.2% ...
Hosted on MSN2d
Audubon’s Globus Medical Makes Game-Changing AcquisitionAudubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...
Stryker sold its U.S. spinal implants to the Viscogliosi Brothers, and market analysts with GlobalData predict the move will benefit competitors in spinal fusio ...
Stryker has agreed to sell its US spinal implants business to the Viscogliosi Brothers. The newly formed company will be ...
GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
A Florida federal judge has issued a report and recommended that a sales representative pay more than $19 million to resolve ...
The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback